Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
exenatide (byetta) (1 trial)
insulin lispro (humalog) (1 trial)
lapatinib (tykerb) (1 trial)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Trials (2 total)
Trial APIs (3 total)